Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CPB1 | P15086 | 2/20 | 0.50 |
| ▸ | CASP3 | P42574 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 3/20 | 0.48 |
| ▸ | CTSK | P43235 | 3/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | TLR4 | O00206 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6758772 | 0.86 | ALDH1A1 (0.52) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL6612597 | 0.85 | EPHX1 (0.63) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL9568182 | 0.83 | CASP3 (0.50) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL4534284 | 0.81 | MEN1 (0.44) | EPHX1ALDH1A1MEN1KMT2A | |
| SCHEMBL10007480 | 0.80 | CASP3 (0.62) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL13326281 | 0.80 | EPHX1 (0.58) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL18544232 | 0.80 | EPHX1 (0.58) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL22204568 | 0.80 | CASP3 (0.62) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL5345577 | 0.80 | CASP3 (0.62) | EPHX1ALDH1A1GAACPB1CASP3 | |
| SCHEMBL13917140 | 0.80 | EPHX1 (0.58) | EPHX1ALDH1A1GAACPB1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6703190-B2 | Method for producing resist structures | INFINEON TECHNOLOGIES AG (DE) | 2004-03-09 | — | — | US | claimed |
| US-20030008240-A1 | Method for producing resist structures | POLARIS INNOVATIONS LIMITED (IE) | 2003-01-09 | — | — | US | claimed |
| EP-1247141-A1 | CREATION OF RESIST STRUCTURES | Infineon Technologies AG (DE) | 2002-10-09 | — | — | EP | claimed |
| WO-2001042860-A1 | CREATION OF RESIST STRUCTURES | INFINEON TECHNOLOGIES AG (DE) | 2001-06-14 | — | — | WO | claimed |
| WO-2001042859-A1 | PRODUCTION OF RESIST STRUCTURES | INFINEON TECHNOLOGIES AG (DE) | 2001-06-14 | — | — | WO | claimed |
| US-20110172421-A1 | N-(alpha-AROMATIC GROUP-SUBSTITUTED-2-NITRO-4,5-DIALKOXYBENZYLOXYCARBONYL)AMINE COMPOUND AND PROCESS FOR PRODUCING THE SAME | SHOWA DENKO K.K. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-7507520-B2 | Composition for forming a conjugated polymer pattern and process of forming a conjugated polymer pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-03-24 | — | — | US | disclosed |
| US-20040180984-A1 | Composition for forming a conjugated polymer pattern and process of forming a conjugated polymer pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-09-16 | — | — | US | disclosed |
| US-6703190-B2 | Method for producing resist structures | INFINEON TECHNOLOGIES AG (DE) | 2004-03-09 | — | — | US | disclosed |
| US-20030008240-A1 | Method for producing resist structures | POLARIS INNOVATIONS LIMITED (IE) | 2003-01-09 | — | — | US | disclosed |
| EP-1247141-A1 | CREATION OF RESIST STRUCTURES | Infineon Technologies AG (DE) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001042860-A1 | CREATION OF RESIST STRUCTURES | INFINEON TECHNOLOGIES AG (DE) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172421-A1 | N-(alpha-AROMATIC GROUP-SUBSTITUTED-2-NITRO-4,5-DIALKOXYBENZYLOXYCARBONYL)AMINE COMPOUND AND PROCESS FOR PRODUCING THE SAME | NME2, DAO, NMBR | EPHX1 1377/4885ALDH1A1 982/4885GAA 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.